Research ArticleTheranostics
90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy
Yusuf Menda, Mark T. Madsen, Thomas M. O’Dorisio, John J. Sunderland, G. Leonard Watkins, Joseph S. Dillon, Sarah L. Mott, Michael K. Schultz, Gideon K.D. Zamba, David L. Bushnell and M. Sue O’Dorisio
Journal of Nuclear Medicine November 2018, 59 (11) 1692-1698; DOI: https://doi.org/10.2967/jnumed.117.202903
Yusuf Menda
1Department of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
Mark T. Madsen
1Department of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
Thomas M. O’Dorisio
2Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
John J. Sunderland
1Department of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
G. Leonard Watkins
1Department of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
Joseph S. Dillon
2Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
Sarah L. Mott
3Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
Michael K. Schultz
1Department of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
Gideon K.D. Zamba
4Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa; and
David L. Bushnell
1Department of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
M. Sue O’Dorisio
5Department of Pediatrics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 11
November 1, 2018
90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy
Yusuf Menda, Mark T. Madsen, Thomas M. O’Dorisio, John J. Sunderland, G. Leonard Watkins, Joseph S. Dillon, Sarah L. Mott, Michael K. Schultz, Gideon K.D. Zamba, David L. Bushnell, M. Sue O’Dorisio
Journal of Nuclear Medicine Nov 2018, 59 (11) 1692-1698; DOI: 10.2967/jnumed.117.202903
90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy
Yusuf Menda, Mark T. Madsen, Thomas M. O’Dorisio, John J. Sunderland, G. Leonard Watkins, Joseph S. Dillon, Sarah L. Mott, Michael K. Schultz, Gideon K.D. Zamba, David L. Bushnell, M. Sue O’Dorisio
Journal of Nuclear Medicine Nov 2018, 59 (11) 1692-1698; DOI: 10.2967/jnumed.117.202903
Jump to section
Related Articles
Cited By...
- Monte Carlo Simulations Corroborate PET-Measured Discrepancies in Activity Assessments of Commercial 90Y Vials
- Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
- Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
- Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies